MAP - Market Access Podcast

Tune in to the latest episode of the Market Access Podcast, where Dr. Stefan Walzer welcomes statistician and Evimed founder Necdet Gunsoy to explore the critical role of statistics in health economics, HTA, and payer strategy. Learn how better collaboration between statisticians and market access teams can drive evidence-based decision-making, improve communication, and support strategic planning...

This is a repost of a popular episode of MAP - Market Access Podcast, from July 15th 2024. Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this e...

What does it take to succeed in Market Access? In this brand new episode of MAP, the Market Access podcast, Dr. Stefan Walzer sits down with industry veteran Adrian Kielhorn, co-author of The Market Access Guide . Together, they unpack the evolving role of market access professionals, the power of strategic thinking, mastering negotiations, and why patient centricity is key to success. Learn how t...

In this brand new episode of MAP, the Market Access Podcast, our host Dr. Stefan Walzer is joined by Dr. Nick Leach, Market Access expert and managing director at Red Thread, to break down the Joint Clinical Assessment (JCA) process, its impact on pharma, biotech, and medical device companies, and how early advice can shape market access and reimbursement strategies in Europe. Tune in to learn abo...

Join the latest episode of the Market Access Podcast, where our host Dr. Stefan Walzer and expert Dr. Ahmed Seddik dissect the complexities of the societal impact of medical innovation. Dr. Ahmed Seddik shares important insights from his journey starting as a dentist in Egypt to his PhD research in health economics and social impact, focusing on how the access to innovation transforms communi...

How can AI revolutionize Market Access, and what does it take to drive successful change in pharma? Tune into the latest episode of MAP, the Market Access Podcast, where our host Dr. Stefan Walzer and Jan Kroschinski, an expert in digital transformation, will delve into change management and AI adoption in pharma. Follow along as they explore how AI can streamline processes like dossier writing an...

In the latest episode of MAP, the Market Access Podcast, our host Dr. Stefan Walzer sits down with Johan Olsson, a seasoned life sciences investor, to uncover the critical role of market access and reimbursement in early-stage healthcare investments. They explore how early market access planning impacts healthcare startups, investment decisions, and commercialization success. Discover why pricing,...

In this episode of MAP, Dr. Stefan Walzer, together with experts Douglas Drake and Adam Skali, unpacks the complexities of how GDPR regulations affect real-world evidence, cross-border studies, and market access in Europe. The discussion highlights data privacy challenges, delays in commercialization, and the future of healthcare data regulation. Learn more about how data privacy laws create barri...

Tune in to the latest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer sits down with Amazon bestselling author Dr. Kasia Hein-Peters to explore the power of structured innovation planning. Get a deeper understanding of how healthcare companies better can balance short-term commercialization with long-term innovation, as well as what roles of AI, digital twins and scenario-based...

Discover the newest episode of MAP, the Market Access Podcast, your go-to podcast for all things Market Access. In todays episode our host Dr. Stefan Walzer dives deep into early market access in commercialization planning, bridging the gap between innovation and market success. Joined by Catherine Bacon, founder of Fingerpost Consulting, the conversation unpacks the critical steps early-stage hea...

This is a repost of a popular episode of MAP - Market Access Podcast, from March 15th 2024. Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights on making impactful career transitions. Market Access...

This is a repost of a popular episode of MAP - Market Access Podcast, from December 15th 2021. Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board. In this wide ranging conversation Dr. Stefan Walzer confronted Prof. Wasem...

This is a repost of a popular episode of MAP - Market Access Podcast, from April 15th 2023. All patients within all populations should have access to high quality medications that improve their health outcomes regardless of race, ethnicity, socio-economic status or any other individual factors,  wrote Dr. Utibe R. Essien in an  Jama article 2021 . But how does reality look like...

This is a repost of a popular episode of MAP - Market Access Podcast, from October 1st 2022. Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next years. Germany has started by implementing digital health applications (“DIGAs”) and is currently on its way to improve the digital infrastructure in hospitals. Anyway, some core questions...

This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023. Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important how could this situation be improved? In this podcast episode, Dr. Stefan Walzer and...

Join us on the latest episode of MAP - the Market Access Podcast - where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs). In this episode, they unpack how healthcare's carbon footprint and environmental impact are influencing po...

This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023.  Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design is important – not only that p...

This is a repost of a popular MAP, Market Access Podcast, from January 2023.  A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also strong advocates of real-world evidence as a complementary way...

In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some core questions: - What are the differences between Clinical De...

Tune in to the latest episode of MAP, the Market Access Podcast, hosted by Dr Stefan Walzer. In this summer special you will hear some profound insights from the recent MArS Webinar about the new platform DO-Bo - the first and only AI bot for creating reimbursement dossiers globally. Alongside Dr. Stefan Walzer you will also hear from Aleksey Zavgorodniy from Ukraine as they dive deep in...

Join us on the latest episode of MAP - the Market Access Podcast - hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management. Explore the latest trends in healthcare market acces...

Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes literature reviews, making the...

Tune in to the new episode of the Market Access Podcast (MAP), where Dr. Stefan Walzer, a pioneer in Market Access 4.0, explores groundbreaking solutions and innovative technologies shaping the future of healthcare reimbursement. Discover how AI-based platforms like Q-Bo and Wafle are revolutionizing health care trainings with all stakeholders. Special guest Rodrigo Silva shares his insights on th...

In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape.  Discover how AI is revolutionizing market research, streamlining dossier pre...

What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond....